Novo Nordisk ADR (NYSE:NVO) traded at $132.14 at last check on Monday, March 18, made a downward move of -0.18% on its previous day’s price.
Looking at the stock we see that its previous close was $132.37 and the beta (5Y monthly) reads 0.17. The company has a trailing 12-month PE ratio of 48.91. In terms of its 52-week price range, NVO has a high of $138.28 and a low of $67.66. The company’s stock has gained about 8.53% over that past 30 days.
Novo Nordisk ADR has a market cap of $447.07 billion. With its Forward Dividend at 1.03 and a yield of 0.78%, the company’s investors could be anxious for the NVO stock to gain ahead of the earnings release.
There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the NVO stock, short term indicators assign the stock an average of 100% Buy, while medium term indicators assign it an average of 100% Buy. Long term indicators on average place the stock in the category of 100% Buy.
Looking further, we note that the PEG ratio for the NVO stock currently stands at 17.47, and the most recent price level today is 4.10% off its SMA20 and 12.22% from its 50-day simple moving average. The RSI (14) is pointing at 60.86 while the volatility over the past week is 2.03% and jumps to 2.00% over the past one month. The beta value is 0.41, while the average true range (ATR) is currently pointing at 3.26.
Coming back to Novo Nordisk ADR (NYSE:NVO), we note that the average 3-month trading volume was 5.08 million, while that of the preceding 10-day period stands at 7.41 million. Current shares outstanding are 3.38 billion.
The insiders hold 0.00% of the company’s shares while institutions hold 9.15%. The data shows that short shares as of Feb 29, 2024, stood at 4.67 million at a short ratio of 0.88. This represents a 0.11% short interest in shares outstanding on Feb 29, 2024. Shares short fall in February from the previous month at 7.52 million. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock 27.73% up in year-to-date price movement.
